|
Recent news stories focusing on an HRT study being abandoned early in the US have sparked concern for women in New Zealand.
The study has created huge debate amongst health professionals and concern in women already taking, or considering taking, HRT. The study was stopped early after women exhibited an increase in the incidence of breast cancer, strokes and blood clots.
The foundation emphasises that HRT has one main indication- to control the symptoms of menopause.
Br Belinda Scott, breast surgeon and chair of the Foundation's Medical Advisory Committee, says women are now advised to use HRT only for these menopausal symptoms.
Women as individuals should re-evaluate whether or not to remain on HRT.
This is something that should be decided upon consultation and discussion with their GP.
"Research has indicated that HRT is not as safe as we initially thought. We have always known of the increased risk in breast cancer with HRT, this is not a new discovery.
What is new is the study's finding that women on HRT could face and increased risk of heart disease and strokes.
"The conditions for which HRT was once prescribed, for example heart disease, hip fractures and other bone density implications, aren't relevant in this form of medication anymore. There are now better drugs available which have been tailored specifically for these conditions, that doctors can prescribe, " says Dr Scott.
"Many women weigh up the benefit of HRT for their individual use and weigh up the personal benefits verses risk. It is important that they make an informed decision after being presented with the facts, and reassess their need for HRT often--every 2 to 3 years," says Dr Scott.
Women on HRT should ensure they attend a regular breast-screening programme or visit their doctor for regular breast examinations.
Source: Breast Health pub The New Zealand Breast Cancer Foundation Spring/Summer 2002
| 
